We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Clover Health Investments
CLOV
$2.4B
| $11.4K | ﹤0.01% |
6,462
+1,222
| +23% | +$2.65K |
|
2102
Accel Entertainment
ACEL
$974M
| $11.2K | ﹤0.01% |
1,031
+254
| +33% | +$2.87K |
|
2103
Liquidity Services
LQDT
$1.17B
| $11.2K | ﹤0.01% |
366
+34
| +10% | +$1.06K |
|
2104
Transcat
TRNS
$816M
| $11K | ﹤0.01% |
150
+8
| +6% | +$563 |
|
2105
Marten Transport
MRTN
$1.38B
| $11K | ﹤0.01% |
+839
| New | +$10.8K |
|
2106
Vitamin Cottage Natural Grocers
NGVC
$676M
| $11K | ﹤0.01% |
426
+183
| +75% | +$4.73K |
|
2107
Schrodinger
SDGR
$1.13B
| $11K | ﹤0.01% |
967
+213
| +28% | +$2.94K |
|
2108
Alpha and Omega Semiconductor
AOSL
$1.01B
| $11K | ﹤0.01% |
495
+81
| +20% | +$1.76K |
|
2109
Taysha Gene Therapies
TSHA
$1.68B
| $11K | ﹤0.01% |
+2,454
| New | +$11.4K |
|
2110
Amerant Bancorp
AMTB
$1.01B
| $11K | ﹤0.01% |
497
+52
| +12% | +$1.12K |
|
2111
Bank First Corp
BFC
$1.65B
| $10.9K | ﹤0.01% |
81
-9
| -10% | -$1.23K |
|
|
MFA
2112
MFA Financial
MFA
$921M
| $10.9K | ﹤0.01% |
1,138
+137
| +14% | +$1.35K |
|
2113
SI-BONE Inc
SIBN
$730M
| $10.9K | ﹤0.01% |
861
+263
| +44% | +$4.12K |
|
|
GLIBK
2114
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$885M
| $10.8K | ﹤0.01% |
+291
| New | +$11K |
|
2115
Blend Labs
BLND
$409M
| $10.8K | ﹤0.01% |
6,351
+3,513
| +124% | +$7.51K |
|
2116
Groupon
GRPN
$966M
| $10.8K | ﹤0.01% |
+906
| New | +$12.1K |
|
2117
Kura Oncology
KURA
$928M
| $10.8K | ﹤0.01% |
1,326
+563
| +74% | +$4.84K |
|
2118
Euronet Worldwide
EEFT
$2.94B
| $10.8K | ﹤0.01% |
162
-124
| -43% | -$8.88K |
|
2119
Skyward Specialty Insurance
SKWD
$2.38B
| $10.7K | ﹤0.01% |
246
-65
| -21% | -$2.95K |
|
|
ARR
2120
Armour Residential REIT
ARR
$2B
| $10.7K | ﹤0.01% |
643
-119
| -16% | -$2.1K |
|
2121
Middlesex Water
MSEX
$1.05B
| $10.7K | ﹤0.01% |
205
+18
| +10% | +$947 |
|
2122
Live Oak Bancshares
LOB
$1.97B
| $10.6K | ﹤0.01% |
322
-26
| -7% | -$958 |
|
2123
PureCycle Technologies
PCT
$1.21B
| $10.6K | ﹤0.01% |
2,045
+329
| +19% | +$2.74K |
|
2124
Apogee Enterprises
APOG
$840M
| $10.6K | ﹤0.01% |
316
+60
| +23% | +$2.22K |
|
2125
Five Star Bancorp
FSBC
$1.01B
| $10.6K | ﹤0.01% |
281
+52
| +23% | +$2K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.